ILMN vs. INCY
ILMN (Illumina, Inc.) and INCY (Incyte Corporation) are both stocks. Both are in the Healthcare sector — ILMN in Diagnostics & Research, INCY in Biotechnology. Over the past 10 years, ILMN returned 1.39%/yr vs 0.83%/yr for INCY. At a 0.34 correlation, their price movements are largely independent.
Performance
ILMN vs. INCY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ILMN achieves a 23.93% return, which is significantly higher than INCY's -6.61% return. Over the past 10 years, ILMN has outperformed INCY with an annualized return of 1.39%, while INCY has yielded a comparatively lower 0.83% annualized return.
ILMN
- 1D
- -1.13%
- 1M
- 19.72%
- YTD
- 23.93%
- 6M
- 27.44%
- 1Y
- 100.46%
- 3Y*
- -6.93%
- 5Y*
- -16.21%
- 10Y*
- 1.39%
INCY
- 1D
- -3.50%
- 1M
- -4.82%
- YTD
- -6.61%
- 6M
- -9.07%
- 1Y
- 41.23%
- 3Y*
- 13.83%
- 5Y*
- 2.16%
- 10Y*
- 0.83%
ILMN vs. INCY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ILMN Illumina, Inc. | 23.93% | -1.85% | -1.34% | -31.14% | -46.85% | 2.82% | 11.53% | 10.61% | 37.27% | 70.64% |
INCY Incyte Corporation | -6.61% | 43.00% | 10.00% | -21.83% | 9.43% | -15.61% | -0.39% | 37.32% | -32.86% | -5.55% |
Correlation
The correlation between ILMN and INCY is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.36 |
Correlation (All Time) Calculated using the full available price history since Jul 31, 2000 | 0.34 |
Fundamentals
ILMN:
$25.03B
INCY:
$19.08B
ILMN:
$5.48
INCY:
$7.06
ILMN:
29.68
INCY:
13.07
ILMN:
14.26
INCY:
0.01
ILMN:
5.76
INCY:
3.49
ILMN:
8.27
INCY:
3.39
ILMN:
$4.39B
INCY:
$5.36B
ILMN:
$2.93B
INCY:
$3.76B
ILMN:
$1.39B
INCY:
$1.80B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ILMN vs. INCY — Risk / Return Rank
ILMN
INCY
ILMN vs. INCY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Illumina, Inc. (ILMN) and Incyte Corporation (INCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ILMN | INCY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.16 | 1.28 | +0.88 |
Sortino ratioReturn per unit of downside risk | 3.10 | 1.97 | +1.13 |
Omega ratioGain probability vs. loss probability | 1.38 | 1.24 | +0.13 |
Calmar ratioReturn relative to maximum drawdown | 3.81 | 2.28 | +1.53 |
Martin ratioReturn relative to average drawdown | 8.64 | 5.15 | +3.49 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ILMN | INCY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.16 | 1.28 | +0.88 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.36 | 0.07 | -0.43 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.03 | 0.02 | +0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.15 | 0.20 | -0.05 |
Drawdowns
ILMN vs. INCY - Drawdown Comparison
The maximum ILMN drawdown since its inception was -96.14%, roughly equal to the maximum INCY drawdown of -98.54%. Use the drawdown chart below to compare losses from any high point for ILMN and INCY.
Loading charts...
Drawdown Indicators
| ILMN | INCY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.14% | -98.54% | +2.40% |
Max Drawdown (1Y)Largest decline over 1 year | -25.66% | -18.33% | -7.33% |
Max Drawdown (3Y)Largest decline over 3 years | -65.68% | -33.83% | -31.85% |
Max Drawdown (5Y)Largest decline over 5 years | -86.23% | -41.53% | -44.70% |
Max Drawdown (10Y)Largest decline over 10 years | -86.23% | -66.47% | -19.76% |
Current DrawdownCurrent decline from peak | -68.16% | -39.58% | -28.58% |
Average DrawdownAverage peak-to-trough decline | -40.37% | -59.92% | +19.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.30% | 8.11% | +3.19% |
Volatility
ILMN vs. INCY - Volatility Comparison
Illumina, Inc. (ILMN) has a higher volatility of 8.77% compared to Incyte Corporation (INCY) at 6.43%. This indicates that ILMN's price experiences larger fluctuations and is considered to be riskier than INCY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ILMN | INCY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.77% | 6.43% | +2.34% |
Volatility (6M)Calculated over the trailing 6-month period | 28.92% | 22.29% | +6.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.70% | 32.37% | +14.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.61% | 29.24% | +16.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 42.14% | 34.23% | +7.91% |
Dividends
ILMN vs. INCY - Dividend Comparison
Neither ILMN nor INCY has paid dividends to shareholders.
Financials
ILMN vs. INCY - Financials Comparison
This section allows you to compare key financial metrics between Illumina, Inc. and Incyte Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ILMN vs. INCY - Profitability Comparison
ILMN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Illumina, Inc. reported a gross profit of 721.00M and revenue of 1.09B. Therefore, the gross margin over that period was 66.1%.
INCY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported a gross profit of 0.00 and revenue of 1.27B. Therefore, the gross margin over that period was 0.0%.
ILMN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Illumina, Inc. reported an operating income of 209.00M and revenue of 1.09B, resulting in an operating margin of 19.2%.
INCY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported an operating income of 301.12M and revenue of 1.27B, resulting in an operating margin of 23.7%.
ILMN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Illumina, Inc. reported a net income of 134.00M and revenue of 1.09B, resulting in a net margin of 12.3%.
INCY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported a net income of 303.33M and revenue of 1.27B, resulting in a net margin of 23.8%.
Frequently Asked Questions
ILMN and INCY have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ILMN has higher volatility (8.77%) compared to INCY (6.43%). In terms of maximum drawdown, ILMN dropped -96.14% vs INCY's -98.54%.
ILMN currently has the higher Sharpe Ratio (2.16 vs 1.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ILMN and INCY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer